About This Page
This is a clinician-written, evidence-based summary aligned to the 2026 MLA Content Map. It is intended for medical students and junior doctors preparing for the UKMLA. Always cross-reference with NICE guidance, local protocols, and clinical judgement.
Key points
- 5 Ps: Pruritic, Purple, Polygonal, Planar (flat-topped) Papules/Plaques
- Wickham's striae: fine white lacy lines on surface — pathognomonic
- Koebner positive. Flexor surfaces (wrists, ankles) — opposite to psoriasis
- Oral LP: white reticular pattern on buccal mucosa. Erosive form is premalignant (~1% SCC risk)
- Self-limiting ~18 months for cutaneous. Screen for hepatitis C
Overview
Lichen planus is a T-cell mediated inflammatory condition affecting skin, oral mucosa, nails, and hair. Characteristic violaceous flat-topped papules with Wickham's striae. Cutaneous LP self-limiting in ~65% within 18 months. Erosive oral LP has ~1% malignant transformation risk. Associated with hepatitis C.
Epidemiology
~1% of population. Peak 30-60 years. Female preponderance. Drug triggers (lichenoid eruptions): gold, antimalarials, thiazides, NSAIDs, ACE inhibitors.
Clinical Features
Symptoms
Intensely pruritic violaceous flat-topped polygonal papules — 5 Ps
Flexor surfaces: wrists (most common), ankles, lower back
Oral: white reticular lacy pattern on buccal mucosa (often asymptomatic)
Erosive oral LP: painful erosions and ulceration
Nail: longitudinal ridging, pterygium
Signs
Violaceous flat-topped papules with Wickham's striae
Koebner phenomenon
Oral: bilateral white reticular pattern on buccal mucosa
Post-inflammatory hyperpigmentation as lesions resolve
Investigations
First-line
Clinical diagnosisWickham's striae on dermoscopy aids diagnosis
Skin biopsyBand-like lymphocytic infiltrate, saw-tooth rete ridges, civatte bodies
Second-line
Hepatitis C serologyScreen all patients with lichen planus
DIFShaggy fibrin deposition along basement membrane
Management
BAD Guidelines + NICE CKS1
Cutaneous LP
- Potent topical corticosteroid for symptomatic lesions
- Reassurance: self-limiting ~65% within 18 months
- Extensive: NB-UVB, oral retinoids, short course prednisolone
2
Oral LP
- Reticular: often asymptomatic — monitor only
- Erosive: potent topical steroid mouthwash or tacrolimus
- Long-term follow-up: ~1% SCC transformation risk
Complications
- Post-inflammatory hyperpigmentation
- Oral SCC: ~1% transformation risk from erosive oral LP
- Scarring alopecia: From lichen planopilaris
- Vulvovaginal scarring/stenosis
UKMLA Exam Tips
- 15 Ps: Pruritic, Purple, Polygonal, Planar, Papules
- 2Wickham's striae = pathognomonic
- 3FLEXOR surfaces — opposite to psoriasis (EXTENSOR)
- 4Erosive oral LP: malignant transformation risk (SCC)
- 5Screen for hepatitis C in all LP patients
- 6Koebner: also in psoriasis, vitiligo, warts
Put your reading into practice
Topic-specific question practice is not linked for this article yet.
Choose UKMLA questions from the existing bank. General exam practice covers your selected topics; it is not filtered to this article. Your usual question-bank access applies.
Choose UKMLA practiceAfter your session, return to this section to revisit the reading and choose your next review.
Verified Sources & References
related resources
Save your place and choose what comes next
Dermatology · Article 24 of 25